Effects of high-intensity interval training on biomarkers and inflammatory factors in patients with heart failure: a meta-analysis of randomized controlled trials

高强度间歇训练对心力衰竭患者生物标志物和炎症因子的影响:一项随机对照试验的荟萃分析

阅读:2

Abstract

BACKGROUND: There is still controversy about the effect of high-intensity interval training (HIIT) on the levels of cardiac and inflammatory biomarkers in patients with heart failure compared with moderate-intensity continuous training (MCT) and conventional healthcare activities. This article is to systematically investigate the effects of HIIT on the levels of cardiac and inflammatory biomarkers in patients with heart failure compared with MCT and conventional healthcare activities. METHODS: A computerized search of databases was conducted with the search year from the establishment of the database, and the screened results were subjected to quality assessment and data extraction, and the data was meta-analyzed using RevMan 5.4.1 software. RESULTS: 11 randomized controlled trials (RCTs) were finally included (7 RCTs about BNP and NT-proBNP, 2 RCTs about inflammatory factors, and 2 RCTs involve both), containing a total of 904 study subjects, 457 in the observation group, and 447 in the control group. Meta-analysis showed that HIIT significantly reduced BNP and NT-proBNP levels in patients with heart failure compared with the control group (SMD = -1.33, 95% CI: -2.55∼-0.11, P = 0.03), while it had no significant effect on the level of CRP (SMD = -0.08, 95% CI: -0.33∼0.18, P = 0.56), TNF-α (MD = -0.11, 95% CI: -0.29∼0.08, P = 0.26), and IL-6 (MD = 0.3, 95% CI: -1.95∼2.55, P = 0.8). CONCLUSIONS: Compared with MCT and conventional healthcare activities, the implementation of HIIT in patients with heart failure can effectively reduce the levels of heart failure biomarkers and improve their health. However, the difference between HIIT and the control group was not significant in the regulation of inflammatory factors. SYSTEMATIC REVIEW REGISTRATION: https://www.crd.york.ac.uk/PROSPERO/#searchadvanced, PROSPERO CRD42024513099.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。